Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MGY vs GSK✓SelectedUSD · GSKMGY vs GSK performance historyLatest closeAs of-2.15%11/18
Stock and ETF performance explorer

MGY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+162.0%
GSK return
+72.4%
Excess return
+89.6%
Maximum drawdown
-77.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-1.3%-0.8%-1.8%
7D-2.3%-3.1%+0.9%-1.5%
30D-8.0%-0.9%-7.1%-8.0%
3M-12.9%-4.2%-8.7%-12.4%
6M-21.1%-1.6%-19.5%-21.3%
YTD+9.1%+2.6%+6.5%+6.3%
1Y+5.2%+6.2%-1.0%+1.5%
3Y+15.6%+55.0%-39.4%-4.3%
5Y+30.9%+42.8%-12.0%+9.4%
All+162.0%+72.4%+89.6%+100.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling